The company won the right in a 3-2 vote last week
“We are proud to deepen our roots in the Garden State"
MedMen initially requested regulators approve the transaction in March 2021
The expansion is part of a licensing agreement between the two companies
It will be used to repay “substantially all” of Ascend’s outstanding debt
The MSO is expected to close the offering on May 4th, 2021